Low-dose UVA1 Radiation in Cutaneous Lupus Patients - Trial NCT01776190
Access comprehensive clinical trial information for NCT01776190 through Pure Global AI's free database. This phase not specified trial is sponsored by Ben Chong and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 6 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ben Chong
University of Texas Southwestern Medical Center
Timeline & Enrollment
N/A
Sep 01, 2012
Sep 01, 2022
Primary Outcome
Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Activity Score
Summary
The investigators are conducting an open-label clinical trial determining the effects of UVA1
 phototherapy on cutaneous lupus (CLE) patients. Past research on systemic lupus (SLE)
 subjects indicates that this treatment is likely to be effective in treating cutaneous lupus
 with few side effects. The fact that most CLE patients are seen at dermatology clinics also
 increases the usefulness of this study because there is a large probability that phototherapy
 treatment will be accessible for many of the patients that stand to benefit from it.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01776190
Device Trial